At Investor Conferences

Advertisement

Picture Wirtschaftsförderung Sachsen Life Sciences in Saxony 650x100px

News > All

Total search results: 1077 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Sotio Biotech a.s.. (11/29/22). "Press Release: Sotio Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences". Prague. 2022-11-29
Full-Life Technologies Ltd.. (11/29/22). "Press Release: Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-focused Radiopharmaceutical Pipeline". Brussels, Watchung, NJ & Shanghai. 2022-11-29
Strand Therapeutics Inc.. (11/28/22). "Press Release: Strand Therapeutics Announces Series A1 Bringing Total Round to US$97 Million". Boston, MA. 2022-11-28
V7 Ltd.. (11/28/22). "Press Release: V7 Raises a $33m Series A to Help Teams Build Robust AI, Faster". London. 2022-11-28
Fujifilm Corporation. (11/22/22). "Press Release: Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility". Tokyo. 2022-11-22
Catalym GmbH. (11/22/22). "Press Release: Catalym Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors". Oxford. 2022-11-22
Uniqure N.V.. (11/22/22). "Press Release: Uniqure Announces FDA Approval of First Gene Therapy for Adults with Hemophilia B". Research Triangle Park, NC. 2022-11-22
Accession Therapeutics. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford. 2022-11-21
Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain. 2022-11-17
Kriya Therapeutics, Inc.. (11/16/22). "Press Release: Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio". Redwood City, CA & Research Triangle Park, NC. 2022-11-16
Rentschler Biopharma SE. (11/16/22). "Press Release: Rentschler Biopharma Appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board". Laupheim. 2022-11-16
BioNTech SE. (11/14/22). "Press Release: BioNTech Expands Global Footprint by Acquiring GMP Manufacturing Site to Establish First mRNA Facility in Singapore". Mainz & Singapore. 2022-11-14
NRG Therapeutics Ltd.. (11/9/22). "Press Release: NRG Therapeutics Announces £16 Million Series A to Advance Mitochondrial Therapeutics for Parkinson’s and ALS". Stevenage. 2022-11-09
BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". 2022-11-08
PrecisionLife Ltd.. (11/8/22). "Press Release: PrecisionLife to Evaluate Precision Medicine Potential of Sosei Heptares Neuroscience GPCR Target". 2022-11-08
Insilico Medicine. (11/8/22). "Press Release: Insilico Medicine Signs Strategic Research Collaboration with Sanofi Worth up to $1.2 Billion". New York, NY. 2022-11-08
Novadip Biosciences S.A.. (11/3/22). "Press Release: Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million". Mont-Saint-Guibert. 2022-11-03
Exscientia plc. (11/3/22). "Press Release: Exscientia Expands Biologics Design Capability with Automated Laboratory". Oxford. 2022-11-03
Enzyre B.V.. (11/2/22). "Press Release: Enzyre Closes Series A Financing Round of EUR 12M to Advance Pioneering Diagnostic Technology Platform for Hemophilia Patients". Nijmegen. 2022-11-02
ASC Oncology GmbH. (11/1/22). "Press Release: ASC Oncology Proudly Announces New Partnership with Tamer Group". Berlin. 2022-11-01
Memo Therapeutics AG. (11/1/22). "Press Release: Memo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology Targets". Schlieren. 2022-11-01
Eagle Genomics Ltd.. (10/31/22). "Press Release: Eagle Genomics Announces USD 20M First Close, Scale-up Funding to Accelerate the Application of Microbiome Science for Global ‘One Health’ Innovation". Cambridge. 2022-10-31
Normunity, Inc.. (10/25/22). "Press Release: Normunity Announces $65 Million Series A Financing to Expand the Frontier of Precision Immuno-oncology with Immune Normalizer Therapies". Boston, MA & West Haven, CT. 2022-10-25
Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim. 2022-10-24
FyoniBio GmbH. (10/20/22). "Press Release: FyoniBio and Strike Pharma Sign a Master Service Agreement Covering Cell Line Development for a Novel Bi-specific Therapeutic mAb". Berlin & Stockholm. 2022-10-20
Co.don AG. (10/17/22). "Pressemitteilung: Vereinbarung über die Veräußerung des Geschäftsbetriebs". Teltow & Leipzig. 2022-10-17
Matchpoint Therapeutics, Inc.. (10/14/22). "Press Release: Matchpoint Therapeutics Launches with $100 Million to Deliver on the Promise of Precision Covalent Medicines for Immune Diseases". Cambridge, MA. 2022-10-14
BioM Biotech Cluster Development GmbH. (10/12/22). "Press Release: Osaka and Munich Continue Their Cuccessful Partnership". 2022-10-12
Immunic, Inc.. (10/10/22). "Press Release: Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing". New York, NY. 2022-10-10
Cellarity Inc.. (10/4/22). "Press Release: Cellarity Announces Close of $121 Million Series C Financing". Somerville, MA. 2022-10-04
Azenta, Inc.. (10/3/22). "Press Release: Azenta Announces Completion of B Medical Systems Acquisition". Chelmsford, MA. 2022-10-03
Pheon Therapeutics Ltd.. (9/28/22). "Press Release: Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors". London. 2022-09-28
Kupando GmbH. (9/26/22). "Press Release: Kupando Raises €13 Million in Series A Funding Round". Schönefeld. 2022-09-26
GSK plc. (9/22/22). "Press Release: GSK and Spero Therapeutics Announce Exclusive Licence Agreement for tebipenem HBr, a Late-stage Antibiotic that May Treat Complicated Urinary Tract Infections". London. 2022-09-22
Merck KGaA. (9/21/22). "Press Release: Merck Opens New € 29 Million Biologics Testing Center in Shanghai". Shanghai. 2022-09-21
Onego Bio Ltd.. (9/20/22). "Press Release: Perfect Day Deepens Investment in Enterprise Biology Business with New Brand Identity, nth Bio, and Announces Partnership with Onego Bio". Salt Lake City, UT. 2022-09-20
Nuvisan ICB GmbH. (9/20/22). "Press Release: Nuvisan Receives US$ 9.6m Grant for a Multi-target Drug Discovery Program on Novel Non-hormonal Contraceptive Medicines". Berlin. 2022-09-20
Forever Healthy Foundation gGmbH. (9/15/22). "Press Release: Rejuvenation Startup Summit 2022 Announces Program and Speakers". 2022-09-15
hC Bioscience, Inc.. (9/13/22). "Press Release: hC Bioscience Appoints Brad Margus to Its Board of Directors". Cambridge, MA. 2022-09-13
Heidelberg Pharma AG. (9/9/22). "Press Release: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate". Ladenburg. 2022-09-09
QLi5 Therapeutics GmbH. (9/7/22). "Press Release: QLi5 Therapeutics Attracts EUR 10 Million in Series A Financing". Dortmund. 2022-09-07
Arsenal Biosciences, Inc.. (9/6/22). "Press Release: Arsenal Biosciences Closes $220 Million Series B Financing to Advance Programmable Cell Therapy Programs into Clinical Development". South San Francisco, CA. 2022-09-06
Arcensus GmbH. (9/5/22). "Press Release: Dammam Valley/KSA to Acquire the Majority of Arcensus GmbH/Germany to Accelerate the Global implementation of Whole Genome Sequencing in Genetic Diagnostics and Delivery of Breakthrough Technologies in Genomic Bio 2022-09-05
Heidelberg Pharma AG. (8/30/22). "Press Release: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure [ Not for US, CA, et al.]". Ladenburg. 2022-08-30
Oncgnostics GmbH. (8/25/22). "Press Release: German Oncgnostics GmbH‘s Innovation in the Area of Cervical Cancer Diagnostics Now also Available in China". Jena. 2022-08-25
Evotec SE. (8/25/22). "Press Release: Evotec Expands Clinical and Commercial Drug Substance Manufacturing with Acquisition of Central Glass Germany". Hamburg. 2022-08-25
eTheRNA Immunotherapeutics N.V.. (8/23/22). "Press Release: mRNA Leading Expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA". Niel. 2022-08-23
Adelis Equity Partners. (8/22/22). "Press Release: Adelis Equity Partners Raises Fund Continuation Vehicle for SSI Diagnostica Group, Enabling Transformational Acquisition". 2022-08-22
SSI Diagnostica A/S. (8/22/22). "Press Release: SSI Diagnostica Continues Strong Growth Journey by Merging with Virginia-based TechLab". 2022-08-22
Navis Capital Partners. (8/9/22). "Press Release: Navis Capital Partners Announces the Sale of 100% of B Medical Systems to Azenta, Inc". Singapore. 2022-08-09
Azenta, Inc.. (8/8/22). "Press Release: Azenta Announces Agreement to Acquire B Medical Systems". Chelmsford, MA. 2022-08-08
F2G Ltd.. (8/4/22). "Press Release: F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim". Manchester. 2022-08-04
Amgen Inc.. (8/4/22). "Press Release: Amgen to Acquire ChemoCentryx for $4 Billion in Cash". Thousand Oaks, CA & San Carlos, CA. 2022-08-04
Sanofi S.A.. (8/4/22). "Press Release: Sanofi and Innovent Biologics Enter Strategic Collaboration to Accelerate Development of Oncology Medicines and Expand Presence in China". Paris. 2022-08-04
Sosei Group Corporation (d/b/a Sosei Heptares). (8/2/22). "Press Release: Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological Diseases". Tokyo & Cambridge. 2022-08-02
Eppendorf SE. (8/1/22). "Press Release: Eppendorf Opens New Site in Singapore". Singapore & Hamburg. 2022-08-01
Manifold Biotechnologies, Inc.. (7/14/22). "Press Release: Manifold Bio Raises $40 Million Series A to Expand In Vivo Biologics Design Platform". Boston, MA. 2022-07-14
Heidelberg Pharma AG. (7/13/22). "Press Release: Heidelberg Pharma and Chiome Bioscience Sign Exclusive, Target-Specific Research and Option Agreement for the Development of an Antibody Drug Conjugate (ad hoc)". Ladenburg. 2022-07-13
BeiGene, Ltd.. (7/13/22). "Press Release: BeiGene Appoints Chan Lee as General Counsel". Cambridge, MA, Basel & Beijing. 2022-07-13
Epic Bio (Epicrispr Biotechnologies, Inc.). (7/12/22). "Press Release: Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine with Epigenetic Engineering". South San Francisco, CA. 2022-07-12
Phytolon Ltd.. (7/7/22). "Press Release: Biotech Food Colorant Startup Phytolon Closes $14.5 Million Series A Funding Round, Led by DSM Venturing". Yokneam Illit. 2022-07-07
BeiGene, Ltd.. (7/6/22). "Press Release: BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies". Cambridge, MA, Basel & Beijing. 2022-07-06
Urovant Sciences. (7/5/22). "Press Release: Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland". Basel & 2022-07-05
Mogrify Ltd.. (7/5/22). "Press Release: Mogrify and Astellas Announce Collaboration to Conduct Research on in vivo Regenerative Medicine Approaches to Address Sensorineural Hearing Loss". Cambridge & Tokyo. 2022-07-05
Molzym GmbH & Co. KG. (6/29/22). "Press Release: Molzym Announces Double-Digit Million EUR Capital Increase". Bremen. 2022-06-29
ReCode Therapeutics. (6/29/22). "Press Release: ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M". Menlo Park, CA & Dallas, TX. 2022-06-29
BIO Deutschland e. V.. (6/29/22). "Press Release: President of German Biotechnology Industry Association Elected Chairman of International Umbrella Organization". Berlin. 2022-06-29
F-Star Therapeutics, Inc.. (6/23/22). "Press Release: invoX Pharma to Acquire F-star Therapeutics, Inc. a Pioneering Next Generation Bispecific Discovery Platform and Clinical Programs". London. 2022-06-23
Takeda Pharmaceutical Co. Ltd.. (6/22/22). "Press Release: Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation Efforts". Cambridge, MA. 2022-06-22
Hong Kong Science and Technology Parks (HKSTP). (6/17/22). "Press Release: HKSTP and Boehringer Ingelheim Venture Fund Launch Co-Incubation Programme to Fast-track R&D in Infectious Diseases and Immunology". Hong Kong. 2022-06-17
Mineralys Therapeutics, Inc.. (6/8/22). "Press Release: Mineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance the Development of Novel, Targeted Treatment for Hypertension". Philadeliphia, PA. 2022-06-08
Upstream Bio (US). (6/2/22). "Press Release: Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases". Waltham, MA. 2022-06-02
Transition Bio, Inc.. (6/2/22). "Press Release: Transition Bio Closes $50 Million Series A Financing to Accelerate Biomolecular Condensate Drug Discovery". Cambridge, MA & Cambridge. 2022-06-02
Watchmaker Genomics, Inc.. (6/2/22). "Press Release: Watchmaker Genomics Raises $40M Series A Financing to Accelerate Growth and Expand Clinical Sequencing Product Offerings". Boulder, CO. 2022-06-02
Eurofins Scientific SE. (5/31/22). "Press Release: Eurofins Enhances Its Clinical and BioPharma Service Offering in Japan with Immune Repertoire Analysis Technology Through the Acquisition of Repertoire Genesis Inc.". Luxembourg. 2022-05-31
Transine Therapeutics Ltd.. (5/31/22). "Press Release: Transine Therapeutics Announces Final Closing of Its Seed Round at £13.7m to Accelerate Its Platform and Portfolio Development". Cambridge. 2022-05-31
Full-Life Technologies Ltd.. (5/26/22). "Press Release: Full-Life Technologies Completes $37 Million (USD) Series A Financing to Accelerate Development of Its Radiopharmaceutical Pipeline and Radiotechnology Production Platform". Shanghai & Brussels. 2022-05-26
uMotif Ltd.. (5/25/22). "Press Release: uMotif – the Patient-first Data Capture and Decentralized Clinical Trials Platform – Announces $25.5m of New Investment from a Fund Managed by Athyrium Capital Management". London & New York, NY. 2022-05-25
Sosei Group Corporation (d/b/a Sosei Heptares). (5/17/22). "Press Release: Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery". Tokyo, Cambridge & New York, NY. 2022-05-17
BeiGene, Ltd.. (5/17/22). "Press Release: BeiGene Strengthens European Presence With the Opening of Regional Office in Basel, Switzerland". Cambridge, MA, Basel & Beijing. 2022-05-17
F2G Ltd.. (5/16/22). "Press Release: Shionogi Co., Ltd. and F2G Enter Strategic Collaboration to Develop and Commercialize the New Antifungal Agent Olorofim in Europe and Asia". Osaka & Manchester. 2022-05-16
Enzymaster Deutschland GmbH. (5/12/22). "Press Release: Enzymaster Completes Round-C Financing to Accelerate Innovation, Increase Capabilities, and Expand Capacity". Düsseldorf. 2022-05-12
Domain Therapeutics S.A.. (5/12/22). "Press Release: Domain Therapeutics Raises $42m Series A Financing to Accelerate Clinical Development of Its Best-in-Class and First-in-Class Immuno-oncology Programs". Strasbourg & Montréal, ON. 2022-05-12
Proteona Pte. Ltd.. (5/11/22). "Press Release: Proteona Opens New Laboratory in Singapore. New Facility Will also Serve as Regional Headquarters for Singleron in Asia". Singapore. 2022-05-11
InxMed Co., Ltd.. (5/9/22). "Press Release: InxMed Raised $15 million in Series B+ Financing to Advance Innovative Therapies to Drug-resistant Cancers". Nanjing. 2022-05-09
Hovione. (5/9/22). "Press Release: Hovione and Jixing Announce an Exclusive Global License Agreement for Ophthalmology Program". Lisbon & Shanghai. 2022-05-09
Coriolis Pharma Research GmbH. (5/4/22). "Press Release: Coriolis Pharma Appoints Silvia Steyrer-Gruber as New Chief Executive Officer". Martinsried. 2022-05-04
Bone Therapeutics S.A.. (4/29/22). "Press Release: Bone Therapeutics Announces 2021 Full Year Results". Mont-Saint-Guibert. 2022-04-29
Merck KGaA. (4/29/22). "Press Release: Merck Invests Approximately € 100 Million to Accelerate Single-Use Manufacturing in China". Darmstadt. 2022-04-29
Moderna, Inc.. (4/27/22). "Press Release: Arpa Garay Joins Moderna as Chief Commercial Officer". Cambridge, MA. 2022-04-27
SHS Gesellschaft für Beteiligungsmanagement mbH. (4/21/22). "Press Release: SHS Sells Shares in Bochum-based Phenox GmbH, a Leading Manufacturer of Instruments and Implants for the Treatment of Stroke". Tübingen. 2022-04-21
Tessera Therapeutics. (4/19/22). "Press Release: Tessera Therapeutics Announces Over $300M Series C Financing to Advance its GENE WRITING Platform". Somerville, MA. 2022-04-19
Be Biopharma, Inc.. (4/14/22). "Press Release: Be Bio Closes $130 Million Financing to Pioneer Engineered B Cells, a New Class of Cellular Medicines". Cambridge, MA. 2022-04-14
Terumo Blood and Cell Technologies. (4/13/22). "Press Release: CEO Antoinette Gawin Will Serve as Group Managing Executive Officer in Terumo Corporation’s New Executive Officers’ Management System". Lakewood, CO. 2022-04-13
Bayer AG. (4/13/22). "Press Release: Bayer Receives Approval for Precision Oncology Treatment Vitrakvi in China [Not intended for U.S. and UK Media]". Berlin. 2022-04-13
List Biotherapeutics, Inc.. (4/12/22). "Press Release: List Bio Raises $48.4 Million Series A for Global Scale-Up". Seoul. 2022-04-12
Bone Therapeutics S.A.. (4/12/22). "Press Release: Bone Therapeutics Secures EUR 5 Million Financing [Not for US, AU, CA, et al.]". Mont-Saint-Guibert. 2022-04-12
Ansa Biotechnologies, Inc.. (4/11/22). "Press Release: Ansa Biotechnologies Closes Oversubscribed $68 Million Series A Financing to Power the Next Era of DNA-Enabled Industries". Emeryville, CA. 2022-04-11
H. Lundbeck A/S. (4/8/22). "Press Release: Joerg Hornstein to Join Lundbeck as Chief Financial Officer and Head of Corporate Functions". Valby. 2022-04-08
TreeFrog Therapeutics S.A.S.. (4/8/22). "Press Release: TreeFrog Therapeutics Opens Technological Hub in Kobe, Japan, to Drive Partnerships Opportunities in the Field of iPSC-derived Cell Therapies". Kobe. 2022-04-08
1 2 3 4 5 6 7 8 9 10 11  next pagenext page



Advertisement

Picture Wirtschaftsförderung Sachsen Life Sciences in Saxony 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Campus Berlin-Buch GmbH BBC BerlinBioCube Start-up Center 650x300px

» top